Retrospective comparison of CD34-selected allogeneic peripheral blood stem cell transplantation followed by CD8-depleted donor lymphocyte infusions with unmanipulated bone marrow transplantation.
[en] We have previously reported the feasibility of allogeneic CD34-selected PBSC transplantation followed by pre-emptive CD8-depleted DLI (study group). In this report, we retrospectively compare the clinical outcome of the 24 patients included in this study with an historical group of 35 patients receiving unmanipulated marrow (BMT group). Patients in the study group had significantly faster neutrophil and platelet recovery and were discharged earlier than BMT patients. The actuarial 150-day (after DLI) probability of developing grade II-IV acute GVHD was 28% for the study group versus 62% for the BMT group (p=0.002). The actuarial 2-year probability of developing chronic GVHD was similar (37 versus 36% (NS)) but chronic GVHD was significantly delayed in the study group (p=0.003). The actuarial 2-year probability of relapse was 30% in the study group versus 33% in the BMT group (NS). The actuarial 2-year probability of survival was 45% in the study group versus 43% in the BMT group (NS). We conclude that allogeneic transplantation of CD34-selected PBSC followed by pre-emptive CD8-depleted DLI is feasible with rapid engraftment and minimizes the risk of severe GVHD. Large prospective trials are required to confirm these results.
Disciplines :
Hematology
Author, co-author :
Baron, Frédéric ; Centre Hospitalier Universitaire de Liège - CHU > Hématologie clinique
Baudoux, Etienne ; Centre Hospitalier Universitaire de Liège - CHU > Thérapie cellulaire
Fillet, Georges ; Centre Hospitalier Universitaire de Liège - CHU > Hématologie clinique
Beguin, Yves ; Centre Hospitalier Universitaire de Liège - CHU > Hématologie clinique
Language :
English
Title :
Retrospective comparison of CD34-selected allogeneic peripheral blood stem cell transplantation followed by CD8-depleted donor lymphocyte infusions with unmanipulated bone marrow transplantation.
Ferrara, J.L., Levy, R. and Chao, N.J. (1999) "Pathophysiologic mechanisms of acute graft-versus-host disease", Biol. Blood Marrow Transplant. 5, 347-356.
Goerner, M., Cooley, T., Flowers, E.D., Sullivan, K.M., Kiem, H.P., Sanders, J., Martin, P.J. and Storb, R. (2002) "Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias", Biol. Blood Marrow Transplant. 8, 47-56.
Ferrara, J.L. (2000) "Pathogenesis of acute graft-versus-host disease: cytokines and cellular effectors", J. Hematother. Stent Cell Res. 9, 299-306.
Drobyski, W.R. (2000) "Evolving strategies to address adverse transplant outcomes associated with T cell depletion", J. Hematother. Stem Cell Res. 9, 327-337.
Ho, V.T. and Soiffer, R.J. (2001) "The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation", Blood 98, 3192-3204.
Baron, F. and Beguin, Y. (2000) "Adoptive immunotherapy with donor lymphocyte infusions after allogeneic HPC transplantation", Transfusion 40, 468-476.
Barrett, J. and Childs, R. (2000) "The benefits of an alloresponse: graft-versus-tumor", J. Hematother. Stem Cell Res. 9, 347-354.
Slavin, S., Morecki, S., Weiss, L. and Or, R. (2002) "Donor lymphocyte infusion: the use of alloreactive and tumor-reactive lymphocytes for immunotherapy of malignant and nonmalignant diseases in conjunction with allogeneic stem cell transplantation", J. Hematother. Stem Cell Res. 11, 265-276.
Naparstek, E., Or, R., Nagler, A., Cividalli, G., Engelhard, D., Aker, M., GimonManny, N., Sacks, T. and Tochner, Z. (1995) "T-cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapse", Br. J. Haematol. 89, 506-515.
Barrett, A.J., Mavroudis, D., Tisdale, J. and Read, E. (1998) "T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect", Bone Marrow Transplant. 21, 543-551.
Lee, C.K., Gingrich, R.D., deMagalhaes-Silverman, M., Hohl, R.J., Joyce, J.K., Scott, S.D., Wen, B.C. and Schlueter, A. (1999) "Prophylactic reinfusion of T cells for T cell-depleted allogeneic bone marrow transplantation", Biol. Blood Marrow Transplant. 5, 15-27.
Martino, R., Martin-Henao, G., Sureda, A., Altes, A., Canals, C., Brunet, S. and Sierra, J. (2000) "Allogeneic peripheral blood stem cell transplantation with CD34-cell selection and delayed T-cell add-back in adults. Results of a single center pilot study", Haematologica 85, 1165-1171.
Alyea, E.P., Weller, E., Schlossman, R., Canning, C., Webb, I., Doss, D., Mauch, P., Marcus, K., Fisher, D., Freeman, A., Parikh, B., Gribben, J.G. and Soiffer, R.J. (2001) "T-cell-depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect", Blood 98, 934-939.
Schaap, N., Schattenberg, A., Bar, B., Preijers, F., van de Wiel, van Kemenade and De Witte, T. (2001) "Induction of graft-versus-leukemia to prevent relapse after partially lymphocyte-depleted allogeneic bone marrow transplantation by pre- emptive donor leukocyte infusions", Leukemia 15, 1339-1346.
Nakamura, R., Bahceci, E., Read, E.J., Leitman, S.F., Carter, C.S., Childs, R., Dunbar, C.E., Gress, R., Altemus, R., Young, N.S. and Barrett, A.J. (2001) "Transplant dose of CD34(+) and CD3(+) cells predicts outcome in patients with haematological malignancies undergoing T cell-depleted peripheral blood stem cell transplants with delayed donor lymphocyte add-back", Br. J. Haematol. 115, 95-104.
Baron, F., Siquet, J., Schaaf-Lafontaine, N., Baudoux, E., Hermanne, J.P., Fillet, G. and Beguin, Y. (2002) "Pre-emptive immunotherapy with CD8-depleted donor lymphocytes after CD34-selected allogeneic peripheral blood stem cell transplantation", Haematologica 87, 78-88.
Giralt, S., Hester, J., Huh, Y. and Champlin, R. (1995) "CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation", Blood 86, 4337-4343.
Alyea, E.P., Soiffer, R.J., Canning, C. and Ritz, J. (1998) "Toxicity and efficacy of defined doses of CD4+ donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant", Blood 91, 3671-3680.
Shimoni, A., Gajewski, J.A., Donato, M., Martin, T., O'Brien, S., Talpaz, M., Cohen, A., Korbling, M., Champlin, R. and Giralt, S. (2001) "Long-term follow-up of recipients of CD8-depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantation", Biol. Blood Marrow Transplant. 7, 568-575.
Przepiorka, D., Weisdorf, D., Martin, P., Klingemann, H.G., Beatty, P., Hows, J. and Thomas, E.D. (1995) "1994 Consensus Conference on acute GVHD grading", Bone Marrow Transplant. 15, 825-828.
Margolis, J. and Vogelsang, G. (2000) "Chronic graft-versus-host disease", J. Hematother. Stem Cell Res. 9, 339-346.
Baron, F., Baudoux, E., Frère, P., Tourqui, S., Schaaf-Lafontaine, N., Greimers, R., Herens, C., Fillet, G. and Beguin, Y. (2002) "Nonmyeloablative stem cell transplantation (NMSCT) with CD8-depleted or CD34-selected PBSC", J. Hematother Stem Cell Res. 11, 301-314.
Champlin, R., Schmitz, N., Horowitz, M.M., Chapuis, B., Gale, R.P., Goldman, J.M., Montserrat, E. and Ringden, O. (2000) "Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation", Blood 95, 3702-3709.
Blaise, D., Attal, M., Reiffers, J., Michallet, M., Bellanger, C., Pico, J.L., Stoppa, A.M., Payen, C., Marit, G., Bouabdallah, R. and Sotto, J.J. (2000) "Randomized study of recombinant interleukin-2 after autologous bone marrow transplantation for acute leukemia in first complete remission", Eur. Cytokine Netw. 11, 91-98.
Bensinger, W.I., Martin, P., Cliff, R.A., Storer, B., Forman, S., Cliff, R.A., Kashyap, A., Negrin, R.S., Libelly, K., Chauncey, T.R., Storb, R. and Appelbaum, F.R. (2001) "Transplantation of bone marrow as compared with peripheral blood stem cells from HLA identical relatives in patients with hematologic cancers", N. Engl. J. Med. 344, 175-181.
Martinez, C., Urbano-Ispizua, A., Rozman, C., Marin, P., Rovira, M., Sierra, J., Montfort, N., Carreras, E. and Montserrat, E. (1999) "Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation: comparison of recipients of positive CD34 + selected grafts with recipients of unmanipulated grafts", Exp. Hematol. 27, 561-568.
Baron, F. and Beguin, Y. (2002) "Pre-emptive cellular therapy after T-cell depleted allogeneic stem cell transplantation", Biol. Blood Marrow Transplant., In press.
Powles, R., Mehta, J., Kulkarni, S., Treleaven, J., Millar, B., Marsden J. and Singhal, S. (2000) "Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial", Lancet 355, 1231-1237.
Klingemann, H.G. (2001) "Cellular therapy of cancer with natural killer cells: will it ever work?", J. Hematother. Stem Cell Res. 10, 23-26.